Nuvasive Stock Price - NUVA

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 66.53 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Nuvasive Inc NUVA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  1.24 1.9% 66.53 67.27 64.35 64.96 65.29 23:59:48
Bid Price Ask Price Spread Spread % News
63.11 70.19 7.08 10.09% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4,890 519,142 $ 66.07 $ 34,302,292 452,435 43.51 - 69.51
Last Trade Time Type Quantity Stock Price Currency
16:07:44 priorref 1,001 $ 66.53 USD

Nuvasive Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.46B 52.05M $ 12.48M 0.22 61.70 48.00M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 2.00 7.80%

more financials information »

Nuvasive News

Loading Messages....

Latest NUVA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NUVA Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week63.3867.2762.7663.8683380k3.154.97%
1 Month65.6768.639960.3564.6244438k0.861.31%
3 Months58.9669.156.520864.4746434k7.5712.84%
6 Months53.9869.152.962.0739404k12.5523.25%
1 Year69.2169.5143.5157.8151562k-2.68-3.87%
3 Years66.5381.679243.5160.4424693k0-
5 Years34.381.679234.040157.0975627k32.2393.97%

Nuvasive Description

NuVasive Inc is a medical-device company focused on minimally invasive surgical products and integrated solutions for spine surgery. The firm's spine surgery products contribute the majority of revenue. Its key offering is the maximum access surgery minimally disruptive surgical platform, which minimizes soft-tissue disruption and contact with critical nerves and maximizes visualization during spine fusion surgery. NuVasive also develops biologics used to aid in the spinal fusion or bone-healing processes, such as a collagen-based synthetic bone substitute and synthetic bone-graft material. NuVasive generates the majority of its revenue in the United States.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.